Our comprehensive assessment of Moldova's operating environment and the outlook for its leading sectors are formed by bringing together a wealth of data on global markets that affect Moldova, as well as the latest industry developments that could impact Moldova's industries. This unique integrated approach has given us an impeccable track-record for predicting important shifts in the markets, ensuring you’re aware of the latest market opportunities and risks in Moldova before your competitors.
Moldova Country Risk
Moldova Industry Coverage (2)
Pharmaceuticals & Healthcare
Moldova Pharmaceuticals & Healthcare
BMI View: While short-term prospects for the Moldovan pharmaceutical market present limited opportunities for investors, long term opportunities in the region show great potential. With Moldovan relationships strengthening between China and Europe, the Pharmaceutical market is expected to grow as a result in the long term. Moldova's economic outlook will continue to have a significant impact on the pharmaceutical market's growth trajectory over the forecast period.
Headline Expenditure Projections
Pharmaceuticals: MDL4.90bn (USD350mn) in 2014 to MDL5.18bn (USD408mn) in 2015; +5.7% in local currency terms and +17.0% in US dollar terms.
Healthcare: MDL12.05bn (USD860mn) in 2014 to MDL12.84bn (USD1.01bn) in 2015; +6.6% in local currency terms...
BMI View: The fixed broadband sector continues to outperform the mobile and fixed telephony sectors as huge investments in fibre optic network deployments are matched by strong demand for high speed internet connectivity and convergence services. This trend will continue for ost of our forecast period to 2018, although this could be counterbalanced by mobile broadband services following the roll out of 4G LTE services by the country's two biggest mobile operators. The demand for data services bodes well for telecoms service providers in Moldova which are hard-pressed by the decline in basic voice service revenues.
The mobile market grew by 3.9% q-o-q in Q314 and 4.4% y-o-y at the end of the same period to partially offset the market contraction in FY13.